secwatch.observer — SEC 8-K summary
======================================

Issuer:     ClearPoint Neuro, Inc. (CLPT)
CIK:        0001285550
Form:       8-K
Filed at:   2026-03-17T23:59:59+00:00
Accession:  0001193125-26-110780
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

ClearPoint Neuro reports Q4 revenue $10.4M (+34% YoY); FY 2025 revenue $37.0M (+18%); guides FY 2026 $52-56M
--------------------------------------------------------------------------------

- Q4 2025 revenue $10.4M including $1.2M from recent IRRAS acquisition; organic growth 19% YoY.
- Full-year 2025 revenue $37.0M, 11th consecutive year of growth; 14% organic YoY increase.
- 2026 revenue guidance $52-56M, reflecting expected double-digit growth across all four product segments.
- Completed IRRAS acquisition in Nov 2025, adding neurocritical care line and $20M additional financing from Oberland Capital.
- Cash and equivalents $45.9M at Dec 31, 2025, up from $20.1M a year ago.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1285550/000119312526110780/0001193125-26-110780-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1285550/000119312526110780/clpt-20260317.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-110780

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer